Impact of APOE-ε alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study

PLoS One. 2024 Apr 18;19(4):e0292576. doi: 10.1371/journal.pone.0292576. eCollection 2024.

Abstract

Background: The Apolipoprotein E (APOE) gene has been established in the Alzheimer's disease (AD) literature to impact brain structure and function and may also show congruent effects in healthy older adults, although findings in this population are much less consistent. The current study aimed to replicate and expand the multimodal approach employed by Honea et al. Structural magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), and neuropsychological measures were used to investigate the impact of APOE-ε status on grey matter structure, white matter integrity, and cognitive functioning.

Methods: Data were obtained from the Alzheimer's Disease Initiative Phase 3 (ADNI3) database. Baseline MRI, DTI and cognitive composite scores for memory (ADNI-Mem) and executive function (ADNI-EF) were acquired from 116 healthy controls. Participants were grouped according to APOE allele presence (APOE-ε2+ N = 17, APOE-ε3ε3 N = 64, APOE-ε4+ N = 35). Voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) were used to compare grey matter volume (GMV) and white matter integrity, respectively, between APOE-ε2+ and APOE-ε3ε3 controls, and again between APOE-ε4+ and APOE-ε3ε3 controls. Multivariate analysis of covariance (MANCOVA) was used to examine the effects of APOE polymorphism on memory and EF across all APOE groups with age, sex and education as regressors of no interest. Cognitive scores were correlated (Pearson r) with imaging metrics within groups.

Results: No significant differences were seen across groups, within groups in MRI metrics, or cognitive performance (p>0.05, corrected for multiple comparisons).

Conclusions: The current study partially replicated and extended previous findings from an earlier multimodal study (Honea 2009). Future studies should clarify APOE mechanisms in healthy ageing by adding other imaging, cognitive, and lifestyle metrics and longitudinal design in larger sample sizes.

MeSH terms

  • Aged
  • Alleles
  • Alzheimer Disease* / pathology
  • Apolipoprotein E2 / genetics
  • Apolipoprotein E4 / genetics
  • Apolipoproteins E / genetics
  • Brain / pathology
  • Cognition
  • Diffusion Tensor Imaging* / methods
  • Humans
  • Neuropsychological Tests

Substances

  • Apolipoprotein E2
  • Apolipoprotein E4
  • Apolipoproteins E
  • ApoE protein, human

Supplementary concepts

  • Alzheimer disease, familial, type 3